Back to top

Tonix Pharma Advances Phase 2 Lyme Disease Vaccine Study

An update from Tonix Pharma ( ($TNXP) ) is now available. On August 3, 2026, Tonix Pharmaceuticals reported it had received official minutes from a...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE: